{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:09:23Z","timestamp":1789578563926,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.clml.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T02:13:15Z","timestamp":1673662395000},"page":"249-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Mohammad Ebad Ur","family":"Rehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmi","family":"Chattaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anber","family":"Mahboob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarnab","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Dharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajeel","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Muaaz","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Faraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2023.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: children's oncology group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2023.01.004_bib0002","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.21873\/invivo.12627","article-title":"Acute lymphoblastic leukemia in children: better transplant outcomes after total body irradiation-based conditioning","volume":"35","author":"Styczynski","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.clml.2023.01.004_bib0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MPH.0000000000002055","article-title":"Comparison of total body irradiation-based versus chemotherapy-based conditionings for early complications of allogeneic hematopoietic stem cell transplantation in children with ALL","volume":"43","author":"Yalcin","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2023.01.004_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0268-960X(92)90019-M","article-title":"Conditioning regimens for allogeneic bone marrow transplantation","volume":"6","author":"Copelan","year":"1992","journal-title":"Blood Rev"},{"key":"10.1016\/j.clml.2023.01.004_bib0005","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/pbc.24702","article-title":"Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years","volume":"60","author":"K\u00fcnkele","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2023.01.004_bib0006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00066-021-01805-1","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"197","author":"Sauer","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clml.2023.01.004_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/131.1.243","article-title":"Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation","volume":"131","author":"Peters","year":"1979","journal-title":"Radiology"},{"key":"10.1016\/j.clml.2023.01.004_bib0008","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.01.004_bib0009","doi-asserted-by":"crossref","first-page":"620.e1","DOI":"10.1016\/j.jtct.2021.03.026","article-title":"Impact of total body irradiation-based myeloablative conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"27","author":"Khimani","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.clml.2023.01.004_bib0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17425255.2017.1360277","article-title":"Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review","volume":"13","author":"Myers","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clml.2023.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pbc.25602","article-title":"Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: a study from the pediatric ALL working group of the Japan society for hematopoietic cell transplantation","volume":"62","author":"Kato","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2023.01.004_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2023.01.004_bib0013","unstructured":"National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Study quality assessment tools. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Date Accessed: June 2022."},{"key":"10.1016\/j.clml.2023.01.004_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias visualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clml.2023.01.004_bib0015","unstructured":"The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.4, 2020. Available at: https:\/\/training.cochrane.org\/online-learning\/core-software\/revman."},{"key":"10.1016\/j.clml.2023.01.004_bib0016","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a pediatric blood and marrow transplant consortium study","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.01.004_bib0018","first-page":"489","article-title":"Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan","volume":"18","author":"Carpenter","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0019","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.01.004_bib0020","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1182\/blood-2011-05-354233","article-title":"No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission","volume":"118","author":"Dini","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.01.004_bib0021","doi-asserted-by":"crossref","first-page":"e28079","DOI":"10.1002\/pbc.28079","article-title":"The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Friend","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2023.01.004_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000205270","article-title":"Marrow transplantation for children with acute leukemia: experience of Pesaro","volume":"82","author":"Giardini","year":"1989","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2023.01.004_bib0023","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bbmt.2011.05.013","article-title":"Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes","volume":"17","author":"Kato","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0024","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.13174","volume":"168","author":"Kato","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2023.01.004_bib0025","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood-2009-03-207001","volume":"115","author":"Klingebiel","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.clml.2023.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbmt.2017.04.015","article-title":"Factors associated with long-term risk of relapse after unrelated cord blood transplantation in children with acute lymphoblastic leukemia in remission","volume":"23","author":"Page","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0027","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41409-020-0854-0","article-title":"Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?\u2014a multicenter EBMT-PDWP study","volume":"55","author":"Willasch","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0028","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00277-013-1820-3","article-title":"Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia","volume":"92","author":"Zheng","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.01.004_bib0029","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10428190903419130","article-title":"Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis","volume":"51","author":"Shi-Xia","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.01.004_bib0030","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to national institutes of health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.01.004_bib0031","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1705295","article-title":"Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation","volume":"37","author":"Andersen","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.01.004_bib0032","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V86.10.3861.bloodjournal86103861","article-title":"In vitro cellular drug resistance in children with relapsed\/refractory acute lymphoblastic leukemia","volume":"86","author":"Klumper","year":"1995","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:41:04Z","timestamp":1761871264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2152265023000162"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.01.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}